Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Connors

Showing results (201-210 of 302) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
American Journal of Hematology|May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaborationChan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Hematological Oncology|January 19, 2021
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 studyMartin Hutchings, John Radford, Stephen M Ansell, et al.
Genome Biology|February 28, 2015
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsEmilia L Lim, Diane L Trinh, David W Scott, et al.
Blood|January 3, 2012
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphomaRobert Kridel, Barbara Meissner, Sanja Rogic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximabYasodha Natkunam, Pedro Farinha, Eric D Hsi, et al.
Bone Marrow Transplantation|September 2, 2018
High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantationErica S Tsang, Diego Villa, Federica Loscocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin LymphomaRadhakrishnan Ramchandren, Ranjana H Advani, Stephen M Ansell, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Pageof 31

Showing results (201-210 of 302) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
American Journal of Hematology|May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaborationChan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Hematological Oncology|January 19, 2021
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 studyMartin Hutchings, John Radford, Stephen M Ansell, et al.
Genome Biology|February 28, 2015
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsEmilia L Lim, Diane L Trinh, David W Scott, et al.
Blood|January 3, 2012
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphomaRobert Kridel, Barbara Meissner, Sanja Rogic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximabYasodha Natkunam, Pedro Farinha, Eric D Hsi, et al.
Bone Marrow Transplantation|September 2, 2018
High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantationErica S Tsang, Diego Villa, Federica Loscocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin LymphomaRadhakrishnan Ramchandren, Ranjana H Advani, Stephen M Ansell, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Pageof 31